Psyence Biomedical Ltd. (PBMWW) stock
PBMWWNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBM
$0.01−0.00 (-2.50%)
Close on Oct 30, 2026Market cap –P/E –Yield –
Psyence Biomedical pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Psyence Biomedical's pe ratio was 0.1× on May 29, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | May 29, 2026 | 0.1× | +0.1 |
| 2025 | Dec 31, 2025 | 0.0× | – |